Optimizing the Management of Patients with Advanced Non-Melanoma Skin Cancers in Community-based Dermatology, Oncology, and Dermato-oncology Practices
Patient and Caregiver Perspectives
Post-Test/Evaluation

Questions marked with a * are required
39%
Contact Information
Credentials/Degree (MD, DO, RN, etc.)
Date of  Participation
What percentage of patients experienced any grade toxicity in EMPOWER CSCC-1?
Which of the following healthcare professionals would you consult with, or refer to, before making treatment recommendations/initiating treatment in patients with complex morbidities?
What is your job role?
What is your type of practice?
How many years have you been in practice?
Please estimate the number of patients with advanced or metastatic basal cell or cutaneous squamous cell carcinomas that you treat each month:
Powered by QuestionPro